LyfeSci Research & Innovation acquires Clinically Media
LyfeSci Research & Innovation agreed to acquire Clinically Media. Reported deal value: Undisclosed. Status: Announced. Sector: clinical research. Target headquarters context: New York City, New York, United States.
This page summarizes publicly available information about the transaction as of 2026-01-12. Figures and status may change as filings and press coverage update.
Today at 6:10 PM LyfeSci Acquires Clinically Media To Bring Patient Recruitment In - House And Expand End -to- End Trial Execution LyfeSci Research & Innovation , a Chicago-based full-service clinical research organization, has acquired Clinically Media to bring patient recruitment in-house and expand its end-to-end clinical trial capabilities, the companies said Monday
Deal timeline
This transaction is classified in clinical research. Figures and status may change as sources update.